Qiming Venture Partners USA Promotes Two
Summary
Qiming Venture Partners USA announced the promotions of two key members of its investment team. Before joining BCG, Dr. French led a global industry-academic consortium focused on cell therapy commercialization. Qiming Venture Partners was founded in China in 2006 and has over $5.5 billion in total assets under management. In January 2017, Qiming launched its first US-based fund, focused on early-stage healthcare opportunities in the United States and Europe. Situated in the major life science hubs of Cambridge, the San Francisco Bay Area and Seattle, it is led by Gary Rieschel and Mark McDade.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected